Asuransi Tambahan Mandiri Medical Care
★ The Insurer’s Play
analytical interpretationLimited read — analysis pending. Likely intent: capture recurring health-protection premiums in a fast-growing private-medical market. Full read pending a Strategic Brief.
Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.
Who this fits — and who it doesn’t
Fit guidance becomes available once this product has a Strategic Brief.
Expert · technical detail
How Health products differ
Fully benchmarked · 93% coverageNo product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.
Direct comparison limited by plan-tiering heterogeneity
Observed: 80 · 99 · 100
Allianz AlliSya caps at age 80; Sun Healthcare Solution Syariah and Prudential PRUwell Medical Syariah both reach ~age 99-100; longest tail wins for younger entrants
POJK 36/2025 effective January 2026 — every health product across the category must apply a co-payment structure. Per-episode vs per-claim vs aggregate annual deductible structures vary; agents must explain the specific mechanism for the product being sold.
Most insurers offer Indonesia-only at entry tier; ASEAN regional coverage (Malaysia/Singapore) at mid-tier; global coverage at top-tier with reduced reimbursement percentage. Allianz AlliSya Flexi reportedly extends to US coverage at top tier.
Sun Healthcare Solution Syariah: 37-45% Ujrah depending on plan (high end on Opal/Safir). AIA Syariah typically 35-40%. Allianz Syariah varies.
Coverage caveat: Per-product detail extraction is at ~50% coverage across the 36 active health products. Cross-product comparisons in Section 5 of any health brief produced this run rely on qualitative observations and structured peer-product references (Allianz AlliSya line, Prudential PRU lines, and the four Sun Life Syariah briefs already produced — healthcare-solution-syariah, shifa-essential, shifa-signature, salam-anugerah-harapan). (sample: ~30 products)
Expert · full Strategic Brief
No Strategic Brief yet for this product — analysis pending.
Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.